THC
15.7–18.4%
CBD
0.3%
G13 Blue Widow is a hybrid cannabis strain by NCGA with up to 18.4% THC. Known for its balanced effects combining body relaxation and mental uplift.
No effect, terpene, flavor or medical-use data specific to G13 Blue Widow has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
18.4% THC
About G13 Blue Widow
This hybrid strain brings a wave of creative and euphoric effects that promote happiness and relaxation, perfect for easing anxiety, depression, or pain, all while boasting a THC content of 18.4% for a solid, approachable potency. Dominated by terpenes like myrcene, caryophyllene, and limonene, it features a delightful berry, blueberry, and sweet flavor profile that makes every session feel like a fruity treat. G13 Blue Widow stands out for its balanced high that combines mental clarity with physical ease, credited to breeder NCGA for crafting a strain that's both flavorful and therapeutically versatile.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about G13 Blue Widow
Is G13 Blue Widow an Indica, Sativa, or Hybrid?
G13 Blue Widow is classified as a hybrid cannabis strain.
What cannabinoid content is reported for G13 Blue Widow?
G13 Blue Widow: 18.4% THC and 0.3% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.